Who owns Bionano Genomics, Inc. (BNGO)? Elite investor 13F holders
2 tracked elite investors reported holding Bionano Genomics, Inc as of 2026-06-30, including Renaissance Technologies LLC, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | BIONANO GENOMICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 57743.00 USD | 51100.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | BIONANO GENOMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1.00 USD | 1.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.